Peripheral Inflammatory Factors and Acute Myocardial Infarction Risk: A Mendelian Randomization Study
References
- Hillerson D, Li S, Misumida N, et al. Characteristics, process metrics, and outcomes among patients with ST-elevation myocardial infarction in rural vs urban areas in the US: A report from the US National Cardiovascular Data Registry. JAMA Cardiol. 2022; 7(10): 1016–1024. DOI: 10.1001/jamacardio.2022.2774
- Li S, Gao X, Yang J, Xu H, Wang Y, Zhao Y, et al. Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry. BMC Med. 2022; 20(1):
217 . DOI: 10.1186/s12916-022-02418-w - Oliveira JB, Soares AASM, Sposito AC. Inflammatory response during myocardial infarction. Adv Clin Chem. 2018; 84: 39–79. DOI: 10.1016/bs.acc.2017.12.002
- von Ehr A, Bode C, Hilgendorf I. Macrophages in atheromatous plaque developmental stages. Front Cardiovasc Med. 2022; 9:
865367 . DOI: 10.3389/fcvm.2022.865367 - Fonseca FA, Izar MC. Role of inflammation in cardiac remodeling after acute myocardial infarction. Front Physiol. 2022; 13:
927163 . DOI: 10.3389/fphys.2022.927163 - Liu S, Jiang H, Dhuromsingh M, Dai L, Jiang Y, Zeng H. Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals. Front Cardiovasc Med. 2022; 9:
1013501 . DOI: 10.3389/fcvm.2022.1013501 - Abbate A, Wohlford GF, Del Buono MG, Chiabrando JG, Markley R, Turlington J, et al. Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials. Eur Heart J Cardiovasc Pharmacother. 2022; 8: 503–510. DOI: 10.1093/ehjcvp/pvab075
- Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2021; 77: 1845–1855. DOI: 10.1016/j.jacc.2021.02.049
- Yang W, Li S, Zhao Y, Sun Y, Huang Y, Cao X, et al. Changes in the expression of interleukin-10 in myocardial infarction and its relationship with macrophage activation and cell apoptosis. Ann Transl Med. 2020; 8(10):
643 . DOI: 10.21037/atm-20-3349 - Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, Amouyel P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2003; 108(20): 2453–2459. DOI: 10.1161/01.CIR.0000099509.76044.A2
- Grune J, Lewis AJM, Yamazoe M, Hulsmans M, Rohde D, Xiao L, et al. Neutrophils incite and macrophages avert electrical storm after myocardial infarction. Nat Cardiovasc Res. 2022; 1(7): 649–664. DOI: 10.1038/s44161-022-00094-w
- Ma Y, Yang X, Villalba N, Chatterjee V, Reynolds A, Spence S, et al. Circulating lymphocyte trafficking to the bone marrow contributes to lymphopenia in myocardial infarction. Am J Physiol Heart Circ Physiol. 2022; 322(4): H622–H635. DOI: 10.1152/ajpheart.00003.2022
- Maracle CX, Agca R, Helder B, Meeuwsen JAL, Niessen HWM, Biessen EAL, et al. Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction. Atherosclerosis. 2018; 270: 33–41. DOI: 10.1016/j.atherosclerosis.2018.01.032
- Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022; 7(1):
78 . DOI: 10.1038/s41392-022-00925-z - Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022; 12(4):
a041302 . DOI: 10.1101/cshperspect.a041302 - Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017; 318(19): 1925–1926. DOI: 10.1001/jama.2017.17219
- Ligthart S, Vaez A, Võsa U, Stathopoulou MG, de Vries PS, Prins BP, et al. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018; 103(5): 691–706. DOI: 10.1016/j.ajhg.2018.09.009
- Sun BB, Maranville JC, Peters JE, et al. Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708): 73–79. DOI: 10.1038/s41586-018-0175-2
- Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman ÅK, Schork A, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020; 2(10): 1135–1148. DOI: 10.1038/s42255-020-00287-2
- Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, et al. Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017; 100(1): 40–50. DOI: 10.1016/j.ajhg.2016.11.007
- Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner K, et al. FinnGen: Unique genetic insights from combining isolated population and national health register data. medRxiv.
2022 . - Yavorska OO, Burgess S. MendelianRandomization: An R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017; 46(6): 1734–1739. DOI: 10.1093/ije/dyx034
- Zhang W, Ghosh D. A general approach to sensitivity analysis for Mendelian randomization. Stat Biosci. 2021; 13(1): 34–55. DOI: 10.1007/s12561-020-09280-5
- Ong JS, MacGregor S. Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner’s perspective. Genet Epidemiol. 2019; 43(6): 609–616. DOI: 10.1002/gepi.22207
- Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol. 2023; 81(2): 168–178. DOI: 10.1016/j.jjcc.2022.07.003
- Shirakawa K, Endo J, Kataoka M, Katsumata Y, Yoshida N, Yamamoto T, et al. IL (Interleukin)-10-STAT3-Galectin-3 axis is essential for osteopontin-producing reparative macrophage polarization after myocardial infarction. Circulation. 2018; 138(18):
2021-2035 . DOI: 10.1161/CIRCULATIONAHA.118.035047 - Meng D, Han S, Jeong IS, Kim SW. Interleukin 10-secreting MSCs via TALEN-mediated gene editing attenuates left ventricular remodeling after myocardial infarction. Cell Physiol Biochem. 2019; 52(4): 728–741. DOI: 10.33594/000000051
- Fan X, Zhang X, Liu LC, Kim AY, Curley SP, Chen X, et al. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes. J Investig Med. 2022; 70(5): 1233–1242. DOI: 10.1136/jim-2021-002008
- Xie SL, Chen YY, Zhang HF, Deng BQ, Shu XR, Su ZZ, et al. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: Implications in acute myocardial infarction. Transl Res. 2015; 165(3): 387–395. DOI: 10.1016/j.trsl.2014.09.001
- O’Brien LC, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Abbate A, et al. Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure. Mol Med. 2014; 20(1): 221–229. DOI: 10.2119/molmed.2014.00034
- Kariž S, Petrovič D. Interleukin-18 promoter gene polymorphisms are not associated with myocardial infarction in type 2 diabetes in Slovenia. Balkan J Med Genet. 2011; 14(1): 3–9. DOI: 10.2478/v10034-011-0011-6
- Gao Y, Tong GX, Zhang XW, Leng JH, Jin JF, Wang NF, et al. Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention. Int Heart J. 2010; 51(2): 75–81. DOI: 10.1536/ihj.51.75
- Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer’s disease: A bidirectional Mendelian-randomization study. Int J Epidemiol. 2021; 50(3): 829–840. DOI: 10.1093/ije/dyaa241
- Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022; 20(1):
3 . DOI: 10.1186/s12916-021-02193-0
DOI: https://doi.org/10.5334/gh.1269 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 5, 2023
Accepted on: Sep 5, 2023
Published on: Oct 6, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Yaxi Chen, Ling Zeng, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.